Sarah Tuller, J.D, RAC has 23 years of experience inRegulatory Affairs (RA), with experience ranging from cell & gene/biologics to small molecule products, with focus areas in ophthalmology, oncology,neurology, and mitochondrial dysfunction. Sarah has held leadership positionsin various pharmaceutical companies, including Tenpoint Therapeutics Ltd asChief Regulatory Officer (CRO), Opus Genetics as CRO and Vice President (VP) ofRA and Medical Writing, Disc Medicine as Global VP of RA and Quality, and AstellasPharma US as a Senior Director of RA and Medical Specialties RA Team Lead.Sarah also worked as Senior Director of RA at Travere Therapeutics, as well asRA Director at aTyr Pharma and Voisin Consulting Life Sciences, and has NDA,BLA, and global MAA submission experience. Sarah's experience in RA and drug development bring a global, unified perspective in the development of new therapeutics.
Sarah Tuller earned an B.S. degree in Chemistry and a JurisDoctorate (JD) degree in Patent Law from the University of Dayton School ofLaw. Sarah is a member of the Bar andhas RA certification from the Regulatory Affairs Professionals Society (RAPS).
